News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioXell S.p.A. Completes Recruitment For Phase IIb Trial Of Elocalcitol In Benign Prostatic Hyperplasia


12/15/2006 10:31:20 AM

MILAN, Italy, Dec. 15, 2006 (PRIME NEWSWIRE) -- BioXell S.p.A. (SWX:BXLN) today announced that it has completed recruitment on schedule for its Phase IIb trial of lead compound Elocalcitol in Benign Prostatic Hyperplasia (BPH). With 532 randomized patients, the trial exceeds by 20 the planned sample size and represents the largest trial run by BioXell until now. Last patient visits are planned for June 2007, with results to be announced in the second half of 2007.

Read at Prime Zone


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES